If you need more lookups,
subscriptions start at $34 USD/month.
Ali Zeaiter Location
Mulhouse, FR
Ali Zeaiter Work
2025 -now VP Oncology Clinical Development @
2024 -now Chief Medical Officer and Co-Founder @
2022 -2025 Vice President Of Clinical Development and Regulatory Affairs @
2018 -2022 Director of Clinical Development @
2018 -2018 Head of Clinical Development Oncology @
2013 -2018 Group Medical Director and Global Development Team Leader @ F. Hoffmann-La Roche Ltd
2010 -2013 Associate Group Medical Director and Global Development Team Leader, Oncology @ F. Hoffmann-L Roche Ltd
2008 -2010 Clinical Science Leader @ F. HOFFMANN-LA ROCHE Ltd
2007 -2008 Clinical Scientist @ F. HOFFMANN-LA ROCHE Ltd
2005 -2006 Medical Project Leader @ Cvitkovic & Associés Consultants España / AAI Pharma
2002 -2006 Medical Oncologist @
Ali Zeaiter Education
Université de Paris XI
MD (D.U. en Cancérologie Clinique)
2004-2005
Université de Paris VII
MD (Certificate of specialization in Medical Oncology)
2003-2005
The Russian State Medical University
MD (Medical Degree Studies)
1995-2002
Ali Zeaiter Summary
Ali Zeaiter, based in Mulhouse, FR, is currently a VP Oncology Clinical Development at Alentis Therapeutics. Ali Zeaiter brings experience from previous roles at Superior Nano, PharmaMar and Servier. Ali Zeaiter holds a 2004 - 2005 MD in D.U. en Cancérologie Clinique @ Université de Paris XI. Ali Zeaiter has 1 emails on RocketReach.
Looking for a different Ali Zeaiter?
Find contact details for 700 million professionals.